Catalyst Wire Dossier Catalyst Wire Dossier

Zyclara 3.75% cream

Imiquimod · AbbVie / Galderma (brand historically marketed as Zyclara)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zyclara 3.75% cream, covering 2020-10-30 to 2020-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis [Phase 3]

See pricing